| Name | 6-methylimidazo[2,1-b][1,3]thiazole-5-carbonitrile |
|---|
| Density | 1.43g/cm3 |
|---|---|
| Molecular Formula | C7H5N3S |
| Molecular Weight | 163.20000 |
| Exact Mass | 163.02000 |
| PSA | 69.33000 |
| LogP | 1.57588 |
| Index of Refraction | 1.745 |
| HS Code | 2934100090 |
|---|
|
~84%
83253-34-3 |
| Literature: MILLENNIUM PHARMACEUTICALS, INC.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; BANNO, Hiroshi; HIROSE, Masaaki; KURASAWA, Osamu; LANGSTON, Steven, P.; MIZUTANI, Hirotake; SHI, Zhan; VISIERS, Irache; VOS, Tricia, J.; VYSKOCIL, Stepan Patent: WO2010/90716 A1, 2010 ; Location in patent: Page/Page column 329 ; |
|
~65%
83253-34-3 |
| Literature: Smaliy, Radomir V.; Chaikovskaya, Aleksandra A.; Pinchuk, Aleksandr M.; Tolmachev, Andrei A. Synthesis, 2002 , # 16 p. 2416 - 2420 |
|
~%
83253-34-3 |
| Literature: Andreani; Bonazzi; Rambaldi; et al. European Journal of Medicinal Chemistry, 1982 , vol. 17, # 3 p. 271 - 274 |
|
~%
83253-34-3 |
| Literature: Andreani; Bonazzi; Rambaldi; et al. European Journal of Medicinal Chemistry, 1982 , vol. 17, # 3 p. 271 - 274 |
| Precursor 5 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |